Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill

Kidney International, Supplement

Volumn 56, Issue 72, 1999, Pages

  Tetta, Giro ^a   Bellomo, Rinaldo ^b   Brendolan, Alessandra ^b   Piccinni, Pasquale ^a   Digito, Antonio ^c   Dan, Maurizio ^d   Irone, Marco ^e   Lonnemann, Gerhard ^f   Moscato, Donatella ^c   Buades, Juan ^a   Greca, Gluseppe L A ^b   Ronco, Claudio ^d  

^a Cyberonics Inc   (Italy)

^b AUSTIN HEALTH   (Australia)

^c SAN BORTOLO HOSPITAL   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e Nephrology and Dialysis ^*  (Germany)

^f Clinica Miramar   (Spain)

Author keywords

Acute renal failure; Cytokines; Hemodynamics; Inflammation; Sepsis

Indexed keywords

SORBENT; TUMOR NECROSIS FACTOR;

ACUTE KIDNEY FAILURE; ARTICLE; COMORBIDITY; CRITICAL ILLNESS; CYTOKINE PRODUCTION; EXTRACORPOREAL CIRCULATION; HEMODYNAMICS; HEMOFILTRATION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPSIS; SIGNAL TRANSDUCTION; TREATMENT PLANNING; ANIMAL; CLINICAL TRIAL; DETOXIFICATION; DISEASE MODEL; INSTRUMENTATION; METHODOLOGY; RENAL REPLACEMENT THERAPY; REVIEW;

ANIMALS; CLINICAL TRIALS; CRITICAL ILLNESS; DISEASE MODELS, ANIMAL; HUMANS; RENAL REPLACEMENT THERAPY; SEPSIS; SORPTION DETOXIFICATION;

EID: 0032702686     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. MORRISON DC, ULEVITCH RY. The effects of bacterial endotoxin on host mediator system. Am J Pathol 93:527-617, 1987
2. GLAUSER MP, ZANETTI G, BAUMGARTNER JD, COHEN J. Septic shock. Pathogenesis. Lancet 338:732-736, 1991
3. MUNOZ C, CARLET J, FITTING C, MISSET B, BLéRIOT JP, CAVAILLON JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754, 1991
4. RANDOW F, SYRBE V, MEISEL C, KRAUSCH D, ZUCKERMAN H, PLATZER C, VOLK HD. Mechanism of endotoxin desensitization. Involvement of interleukin-10 and transforming growth factor β. J Exp Med 181:1887-1892, 1995
5. ZENI F, FREEMAN B, NATHANSON C. Anti-inflammatory therapies to treat sepsis and septic shock. A reassessment. Crit Care Med 25:1095-1100, 1997
6. SILVESTER W, BELLOMO R, RONCO C. Continuous versus intermittent renal replacement therapy in the critically ill, in Critical Care Nephrology, edited by RONCO C, BELLOMO R, Dordrecht, Kluwer Academic Publishers, 1998, pp 1225-1238
7. CANAUD B, MION C. Extracorporeal treatment of acute renal failure. Methods, indications, quantified and personalized therapeutic approach. Adv Nephrol 24:271-281, 1995
8. BELLOMO R, TIPPING P, BOYCE N. Continuous veno-venous hemofiltration with dialysis cytokines from the circulation of septic patients. Crit Care Med 21:522-526, 1993
9. SCHETZ M, FERDINANDE P, VAN DER BERGIIE G, VERWAEST C, LAUWERS P. Removal of pro-inflammatory cytokines with renal replacement therapy. Sense or nonsense? Intensive Care Med 21:169-176, 1995
10. VAN BOMMEL EFH, HESSE CI, JUTTE NH, ZIETSE R, BRUINING HA, WEIMER W. Cytokine kinetics (TNF, ILlβ, IL6) during continuous hemofiltration. A laboratory and clinical study. Contrib Nephrol 116:62-75, 1995
11. BELLOMO R, TIPPING P, BOVCE N. Interleukin-6 and interleukin-8 extraction during continuous venovenous-hemodiafiltration in septic acute renal failure. Renal Fail 17:457-466, 1995
12. MILLAR AB, ARMSTRONG L, VAN DER LINDEN J, MOAT N, EKROTH R, WESTWICK J, SCALLAN M, LINCOLN C. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Tlwrac Sitrg 56:1499-1502, 1993
13. JOURNOIS D, POUARD P, GREELY WJ, MAURIAT P, VOUHE P, SAFRAN D. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery. Anesthesiology 81:1181-1189, 1994
14. GOLDFARB S, GOLFER TA. Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 5:228-232, 1994
15. RONCO C, TETTA C, LUPI A, GALLONI E, BETTINI MC, SERENI L, MARIANO F, DE MARTINO A, MONTRUCCIIIO G, CAMUSSI G, LA GRECO G. Removal for platelet-activating factor in experimental continuous arteriovenous hemofiltration. Crit Care Med 23:99-107, 1995
16. HOFFMANN JN, HARTL WH, DEPPISCH R, FAIST E, JOCIIUM M, INTHORN D. Hemofiltration in human sepsis. Evidence for elimination of immunomodulatory substances. Kidney Int 48:1563-1570, 1995
17. LONNEMANN G, SciiiNDLER R, DiNARELLO CA. Removal of circulating cytokines by hemodialysis membranes in vitro, in Host Defense Dysfunction in Trauma. Shock and Sepsis, edited by FAIST E, MARKEWITZ A, SCHILDBER C, Berlin Heidelberg, Springer-Verlag, 1993
18. GROOTENDORST AF, VAN BOMMEL EF, VAN DER HOVEN B, VAN LEENGOED LA, VAN OSTA AL. High-volume hemofiltration improves rieht ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18:235-240, 1992
19. BELLOMO R, BALDWIN I, COLE L, RONCO C. Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int 53(Suppl 66):S182-S185, 1998
20. LEE PA, MATSON JR, PRYOR RW, HINSHAW LB. Continuous arteriovenous hemofiltration therapy for Stapliylococcus oi/raw-induced septicemia in immature swine. Crit Care Med 21:914-924, 1993
21. LONERGAN JM, ORLOWSKI JP, SATO T, MCIIUGH MJ, ZBOROWSKI M. Extracorporeal endotoxin removal in a canine model of septic shock. ASAIO J 40:M654-M657, 1994
22. BERLOT G, TOMASINI A, SILVESTRI L, GULLO A. Plasmapheresis in the critically ill patient. Kidney Int 53(Suppl 66):S178-S181, 1998
23. TETTA C, CAVAILLON JM, SCHULZE M, RONCO C, GIIEZZI PM, CAMUSSI G, SERRA AM, CURTI F, LONNEMANN G. Removal of cytokines and activated complement components in an experimental model of continuous plasmafiltration coupled with sorbent adsorption. Nephrol Dial Transplant 13:1458-1464, 1998
24. LA GRECA G, BRENDOLAN A, GIIEZZI PM, DE SMET R, TETTA C, GERVASIO R, RONCO C. The concept of sorbents in hemodialysis. (editorial) Int J Artif Organs 21:303-308, 1998
25. TAO W, DEYO DJ, ALPARD SK,VERTREES RA,HOANG V,ZWISCIIENBERGER JB. Significant reduction in circuit pressure with modified plasma separation chamber for a heparin removal device. ASAIO J 45:50-52, 1999
26. PARILLO JE. Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477, 1993
27. BONE RC. Sepsis and its complications. The clinical problem. Crit Care Med 22:58-511,1994
28. MOLDAWER LL. Biology of proinfiammatory cytokines and their antagonists. Crit Care Med 22:S3-S7, 1994
29. SILVESTER W. Mediator removal with CRRT. Complement and cytokines. Am J Kidney Dis 30(Suppl 4):S38-S43, 1997
30. LEVY H, ASH SR, KNAB W, STECZKO J, CARR DJ, BLAKE DE. Systemic inflammatory response syndrome treatment by powdered sorbent pheresis. Biologic-detoxification plasma filtration system. ASAIO J 44:M659-M665, 1998